Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network.
Clicks: 335
ID: 22840
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
82.5
/100
331 views
269 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Computed tomography (CT) is essential for pulmonary nodule detection in diagnosing lung cancer. As deep learning algorithms have recently been regarded as a promising technique in medical fields, we attempt to integrate a well-trained deep learning algorithm to detect and classify pulmonary nodules derived from clinical CT images.Open-source data sets and multicenter data sets have been used in this study. A three-dimensional convolutional neural network (CNN) was designed to detect pulmonary nodules and classify them into malignant or benign diseases based on pathologically and laboratory proven results.The sensitivity and specificity of this well-trained model were found to be 84.4% (95% confidence interval [CI], 80.5%-88.3%) and 83.0% (95% CI, 79.5%-86.5%), respectively. Subgroup analysis of smaller nodules (<10 mm) have demonstrated remarkable sensitivity and specificity, similar to that of larger nodules (10-30 mm). Additional model validation was implemented by comparing manual assessments done by different ranks of doctors with those performed by three-dimensional CNN. The results show that the performance of the CNN model was superior to manual assessment.Under the companion diagnostics, the three-dimensional CNN with a deep learning algorithm may assist radiologists in the future by providing accurate and timely information for diagnosing pulmonary nodules in regular clinical practices.The three-dimensional convolutional neural network described in this article demonstrated both high sensitivity and high specificity in classifying pulmonary nodules regardless of diameters as well as superiority compared with manual assessment. Although it still warrants further improvement and validation in larger screening cohorts, its clinical application could definitely facilitate and assist doctors in clinical practice.
| Reference Key |
zhang2019towardthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhang, Chao;Sun, Xing;Dang, Kang;Li, Ke;Guo, Xiao-Wei;Chang, Jia;Yu, Zong-Qiao;Huang, Fei-Yue;Wu, Yun-Sheng;Liang, Zhu;Liu, Zai-Yi;Zhang, Xue-Gong;Gao, Xing-Lin;Huang, Shao-Hong;Qin, Jie;Feng, Wei-Neng;Zhou, Tao;Zhang, Yan-Bin;Fang, Wei-Jun;Zhao, Ming-Fang;Yang, Xue-Ning;Zhou, Qing;Wu, Yi-Long;Zhong, Wen-Zhao; |
| Journal | the oncologist |
| Year | 2019 |
| DOI |
theoncologist.2018-0908
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.